When tested as a once-daily injection in single and multiple doses varying up to 0.18 mg in healthy normal to overweight volunteers, gastrointestinal adverse events (nausea, diarrhoea, constipation, vomiting) were encountered, but the drug was described as well tolerated
This excess skin can cause hygiene issues, skin irritation, and make clothing fit poorly despite your weight loss success
Filed Under: AI Meets Life Sci, Regulatory affairs
The common side effects reported with GLP-1 weight-loss injections such as Ozempic include: nausea vomiting persistent stomach discomfort constipation diarrhoea bloating reflux-like symptoms fatigue dizziness reduced desire to eat to the point of food aversion For many people, eating becomes uncomfortable rather than supportive
Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study
Differential analysis of intestinal microbiota and metabolites in mice with dextran sulfate sodium-induced colitis